Trademark Overview
On Monday, March 11, 2013, a trademark application was filed for EDEZAK with the United States Patent and Trademark Office. The USPTO has given the EDEZAK trademark a serial number of 79129615. The federal status of this trademark filing is IR CANCELLED - US APPLICATION ABANDONED as of Thursday, June 30, 2016. This trademark is owned by Novartis AG. The EDEZAK trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the prevention and/or treatment of disorders of the nervous system, the immune system, the cardio-vascular system including diabetes and metabolic diseases, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, in oncology, in hematology, in transplantation, in ophthalmology, and in the gastroenterological area; pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases; pharmaceutical preparations for the treatment of bacteria-based diseases; anti-infectives, antivirals, antibiotics, antifungals, vaccines, and diagnostic preparations for medical use
